Consultant Job Description

CONSULTANT

JOB DESCRIPTION

APPOINTMENT

Whole-Time Consultant Haematologist with an interest in Myeloid Disorders and Stem Cell Transplantation to Sheffield Teaching Hospitals NHS Foundation Trust based at Royal Hallamshire Hospital.

Any candidate who is unable for personal reasons to work full-time will be eligible to be considered for the post; if such a person is appointed, modification of the job content will be discussed on a personal basis with the Trust in consultation with consultant colleagues.

SHEFFIELD

Sheffield is England's fourth-largest city, with a population of over half a million, with the wealth of facilities you would expect to find in a major city, yet it is compact, welcoming and accessible. It is a friendly city with a prosperous economy and relatively low cost of living, all of which makes for an excellent quality of life.

It has good rail and road links, with a typical train journey to London St Pancras taking 2 hours. Manchester Airport is also just over an hour away with an ever expanding repertoire of routes to national and international destinations.

The city of Sheffield contains an abundance of entertainment and cultural activities including award-winning theatres, (the Crucible and Lyceum are world-class theatres and major regional attractions), museums and galleries, a variety of clubs and live music venues, and a range of spectator and participation sports. With a thriving cultural industries quarter and a range of city-wide events throughout the year, there is something on offer to suit everyone’s taste and interests.

Sheffield also boasts two of Britain's most popular and successful Universities, which between them attract more than 38,000 students a year

Located on rolling hills and dissected by river valleys, Sheffield is one of the greenest and most wooded cities in Europe. More than a third of the city lies inside the beautiful Peak District National Park, and it is virtually surrounded by open countryside – over half the city’s population live within 15 minutes of open countryside. It is also the greenest city in England, with 175 woodlands and 75 public parks. Sheffield offers a unique proposition of city culture alongside access to some of the most stunning countryside in the UK. This environment, together with the unparalleled strength of the city’s climbing, running, walking and biking communities, sets Sheffield apart from anywhere else in the UK. There is also a wide range of affordable housing and excellent schools on offer.

ORGANISATION PROFILE

Sheffield Teaching Hospitals NHS Foundation Trust is one of the UK’s busiest and most successful NHS foundation trusts. We provide a full range of local hospital and community services for people in Sheffield, as well as specialist care for patients from further afield, including cancer, spinal cord injuries, renal and cardiothoracic services. In addition to community health services, the Trust comprises five of Yorkshire’s best known teaching hospitals.

 The Royal Hallamshire Hospital  The Northern General Hospital  Charles Clifford Dental Hospital  Weston Park Cancer Hospital  Jessop Wing Maternity Hospital

The Trust has a history of high quality care, clinical excellence and innovation in medical research. We are proud to be in the top 20% of NHS Trusts for patient satisfaction and, following its inspection in 2018, the Care Quality Commission has given the Trust an overall rating of ‘Good’ with many areas and services highlighted as ‘Outstanding.’ This means that the Trust is one of only 18 (out of 174 Trusts) to have achieved green in every one of the five domains which the Care Quality Commission use to rate a NHS organisation. We are also the only adult healthcare Trust in the Yorkshire and Humber region to have achieved a Good rating overall.

We strive to promote a culture of continuous quality improvement and encourage our staff to innovate and adopt ‘best practice’ in order to deliver the highest standard of care to our patients.

The Northern General Hospital is the home of the City’s Accident and Emergency department which is also now one of three adult Major Trauma Centres for the Yorkshire and Humber region. A number of specialist medical and surgical services are also located at the Northern General Hospital including cardiac, orthopaedics, burns, plastic surgery, spinal injuries and renal to name a few.

A state-of-the-art laboratories complex provides leading edge diagnostic services. The hospital also provides a wide range of specialist surgery such as orthopaedic, spinal cord, hand and kidney transplantation.

The Royal Hallamshire Hospital has a dedicated neurosciences department including an intensive care unit for patients with head injuries, neurological conditions such as stroke and for patients that have undergone neurosurgery. It also has a gastroenterology department, a large tropical medicine and infectious diseases unit as well as a specialist haematology centre and other medical and surgical services.

Sheffield Teaching Hospitals is home to the largest dental school in the region, a maternity hospital with a specialist neonatal intensive care unit and a world renowned cancer hospital. The Trust is also integrated with the City’s adult NHS community services to support our work to provide care closer to home for patients and preventing admissions to hospital wherever possible.

We have a long tradition of clinical and scientific achievement, including the development of one of the UK’s first Academic Health Sciences Networks.

Through our partnerships with the University of Sheffield, Sheffield Hallam University, other health and social care providers and industry we remain at the forefront of advancements in clinical services, teaching and research.

We have around 17,000 employees, making us the second biggest employer in the city. We aim to reflect the diversity of local communities and are proud of our new and existing partnerships with local people, patients, neighbouring NHS organisations, local authority and charitable bodies.

We strive to recruit and retain the best staff: the dedication and skill of our employees are what make our services successful and we continue to keep the health and wellbeing of our staff as a priority.

Our vision is to be recognised as the best provider of healthcare, clinical research and education in the UK and a strong contributor to the aspiration of Sheffield to be a vibrant and healthy city. We have begun this journey with our staff, partners and patients and we will continue to explore every aspect of our business to ensure we are doing our very best to achieve our vision.

PROUD VALUES

These are the values that all staff at Sheffield Teaching Hospitals NHS Foundation Trust are expected to demonstrate in all that they do.

Patients First – Ensure that the people we serve are at the heart of what we do

Respectful – Be kind, respectful, fair and value diversity

Ownership – Celebrate our successes, learn continuously and ensure we improve

Unity – Work in partnership with others

Deliver – Be efficient, effective and accountable for our actions

For further details of our services and organisational structure, including our Board of Directors, and our future plans please visit www.sth.nhs.uk/about-us

GENERAL DIRECTORATE INFORMATION

Clinical Directorates became operational at the Royal Hallamshire Hospital on 1 April 1991 and are now well established. Clinical Directors are appointed by the Chief Executive for a three year period, subject to annual review.

Haematology sits within the wider Directorate of Communicable Diseases and Specialised medicine (Haematology, Infectious Diseases, HIV medicine, Sexual Health, Dermatology and Immunology & Allergy).

THE WORK OF THE DEPARTMENT

Clinical Haematology Service

All the Haematology inpatient and outpatient facilities for adults (over 16 years of age) in Sheffield are based at the Royal Hallamshire Hospital (RHH), with a population served by the laboratory in Sheffield of around 600,000 and South Yorkshire, North Nottinghamshire, North Derbyshire (formerly North Trent) region of close to 2 million. Haematological services for children up to the age of 16 years are provided by the Haematology department of Sheffield Children’s Hospital.

The inpatient facilities comprise of 3 inpatient wards (P3, P4, O1) co-located with extensive dedicated day-case facilities, an Apheresis Unit (managed by NHSBT) and the Centre for Haemophilia and Thrombosis. A significant amount of chemotherapy of all intensities is administered to out-patients on the Day Ward, as are the majority of blood transfusions, venesections, bone marrow and other procedures. Early follow-up of BMT and intensively treated haemato-oncology patients is also conducted on the day-case unit.

Ambulatory care (based either at home or from two dedicated patient flats on the campus) is offered to clinically eligible patients undergoing myeloma and lymphoma autografts, lymphoma salvage chemotherapy and AML consolidation chemotherapy. The department is hoping to extend the practice of ambulatory care to more therapies over coming years.

For the Northern General Hospital (NGH), the clinical liaison services are provided during the day by Dr S. T. Laidlaw, Associate Specialist, Specialist Registrars and an attending haemostasis consultant.

The department has close links with the British Society for Haematology (BSH, Dr Wright, Vice President/President-elect), the European Society for Blood and Marrow Transplantation (EBMT, Prof Snowden, Secretary), and British Society for Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT, Prof Snowden, President-elect).

Haemato-oncology services

Sheffield Teaching Hospitals (STH) provides tertiary Haemato-oncology services, including all levels of BMT and specialised clinical research services, to over 2 million. The haemato-oncology team at comprises 8 consultants, all participating in intensive chemotherapy and BMT services. Inpatient facilities comprise of 3 wards, with 42 beds for BMT and high-intensity chemotherapy and a dedicated day ward. Decisions are made with the support of the weekly regional MDT meeting, which includes the surrounding satellite hospital referral bases (Barnsley, Rotherham, Doncaster, Worksop and Chesterfield). All cases are discussed at presentation and subsequent treatment points, including inclusion in clinical trials.

Specialised Integrated Haematological Diagnostic Services (SIHMDS) for the regional 2 million population (‘HODS’) are provided on the central Sheffield campus, and are linked into the regional Genomic Laboratory Hub (GLH) for Whole Genome Sequencing (WGS) and other genetic developments (regional co-lead GLH clinician, Professor Snowden).

A national award winning Late Effects Clinic has been long established as a collaboration between adult haematology and paediatric haematology/oncology services, Endocrinology, Reproductive Medicine, Psychiatry and other relevant specialties, and is led by Professor Diana Greenfield, Consultant Nurse

Our dedicated Haemato-oncology/Lymphoma clinical trials team are integral to our clinical service and are present in clinics, on wards and at the MDT. The clinical trial work of the team sits within The Academic Directorate of Communicable Diseases and Specialised Medicine (CDSM), which Dr Chantry leads.

The South Yorkshire Region Blood and Marrow Transplant (BMT) Programme

The South Yorkshire Region Blood and Marrow Transplant Programme principally provides services to adults in Sheffield, Barnsley, Rotherham, Doncaster and Bassetlaw, and Chesterfield (approximately 2 million catchment population). The programme is a collaboration between the clinical services at the Sheffield Teaching Hospitals NHS Foundation Trust and the Apheresis, Cell Processing and Histocompatibility Services of the NHS National Blood & Transplant (NHSBT, based in Sheffield). It also takes specialist referrals from nationally and internationally.

Within STHFT, all levels of BMT/Haematopoietic Stem Cell Transplantation are performed in the refurbished single site Clinical Facility at the Royal Hallamshire Hospital. The NBS provides MHRA/HTA accredited cell processing facilities. All aspects of BMT Programme are currently FACT-JACIE accredited, including for Immune Effector Cells (IECs) and various areas of cell therapy are being actively explored.

The BMT programme has an active Quality Management Programme and the appointee will be expected to actively participate in relevant Clinical Audit and Service Evaluation as well as being central to the organisation of the weekly educational programme, particularly in relation to education and, where necessary, competency testing, in the areas of the Curriculum and FACT-JACIE Standards.

The consolidation of haemato-oncology services within the South Yorkshire region with introduction of MDT based management, in conjunction with increased evidence based BMT practice, has led to increased demands for transplant services in Sheffield, with over 150 adult transplant procedures being performed in 2017/18, including autologous, related donor, unrelated donor and unrelated cord blood allogeneic procedures.

The Sheffield Therapeutic Apheresis Unit is sited within the Day Case Unit of the Haematology Department, Royal Hallamshire Hospital. It is staffed and managed by the NHSBT and provides a Therapeutic Service to the region. Each year more than 300 procedures are performed, mainly stem cell collection, but also plasmapheresis and red cell exchange. Sheffield was the first unrelated peripheral blood and bone marrow collection sites for the Anthony Nolan, BBMR and DKMS outside of London, and is therefore one of the largest donor collection sites nationally.

Nearby, Sheffield Children’s Hospital houses a regional paediatric stem cell transplant programme, which has also been fully accredited by FACT-JACIE standards. Transitional care is active between sites. Rotherham General Hospital provides access to the regional extra-corporeal photopheresis (ECP) service, and collaborates in the management of graft versus host disease. Opportunities may be negotiated to obtain clinical experience in this field.

Laboratory Haematology Service

In line with NICE Improving Outcomes Guidance, Specialist Integrated Haemato-oncology Diagnostic Services (SIHMDS) i.e. Cell Markers (Royal Hallamshire Hospital), Cytogenetics (Sheffield Children’s Hospital), Molecular Haematology (Sheffield Children’s Hospital) and Histopathology (Royal Hallamshire Hospital) are consolidated into the Haematological Oncology Diagnostic Service (HODS) for the South Yorkshore region, with production of integrated reports via a dedicated IT system. Currently HODS is one of the three regional SIMHDS within the Yorkshire, Humber and North East Genomic Laboratory Hub (GLH), with Whole Genome Sequencing (WGS) being integrated into reports via a weekly Genomic Tumour Advisory Boards (GTAB) meeting. Involvement of the appointee in the HODS and GTAB is negotiable, depending on the skillmix and preference of the appointee.

There are modern CPA (UK) accredited laboratories at the RHH and NGH, including blood banking facilities at both sites. The haematology laboratories within STHFT have an integrated management structure consistent with recommendations of the Strategic Review. The UK NEQAS Schemes for Immunophenotyping and Factor Assays are closely associated with the Department of Haematology. Paediatric haematology laboratory services are provided at STHFT for neonates, although are largely situated at Sheffield Children’s Hospital.

Clinical and Translational Research in Haemato-oncology/HSCT in STH and University of Sheffield

Sheffield’s principal academic areas of interest are:  Clinical trials in haematological cancers and BMT  Translational research in haematological cancers and BMT/stem cell biology  Supportive care in cancer, Including a world-leading track record in physical and psychological late effects in survivors of cancer treatment/BMT (with Prof Greenfield)  BMT for severe autoimmune and inflammatory diseases

There as an active and expanding clinical trials research portfolio (Investigator-led and Industry sponsored) via NIHR, ECMC and other networks. Sheffield is a designated and fully supported TAP Clinical Trials and Myeloma UK Clinical Trials Network centre. We are an affiliated IMPACT centre member.

STH is home to NIHR clinical research facilities (CRF and CCTC), which are in close proximity to the haematology wards, day-case and outpatients facilities. Both sites are purpose built facilities including inpatient beds, clinical investigation suites and dedicated laboratory facilities. The CRF is an NIHR Experimental Medicine CRF. All phase I, high risk or novel therapy studies are reviewed by the EM nursing group to ensure safe, high-quality delivery. We have a dedicated EM Research Sister who oversees the EM portfolio. The CRF hosted 9738 patient visits in 2018/19 (2720 of these were EM) and recruited 6267 (651 EM) patients across all phases of research. Haemato-oncology/lymphoma clinical trials are also delivered by the Cancer Clinical Trials Centre (CCTC) at Sheffield. This purpose built clinical research facility was established in 1999, and provides an ideal environment, with consulting rooms, treatment suite and sample processing laboratory, for the assessment and treatment of patients on novel therapies. The CCTC have a particular focus on increasing early phase trial work currently and an early phase trial team has recently been established thanks to the funding support of a local charity.

Sheffield has been a Bloodwise Centre of Excellence for the last seven years status in recognition of its considerable translational research. Examples across the range of haematological cancers and BMT include:  World-leading myeloma bone disease and microenvironment translational research laboratory conducted by the Sheffield Myeloma Research Team (SMaRT) led by Dr Chantry.  Development of unique oncolytic viral therapies in myeloma and lymphoma using a modified adenovirus system, collaborations with Professor Lewis and Dr Muthana.  Genetic epidemiological studies in CLL, myeloma and symptoms related to haematological cancers, collaborations with Professor Cox.  A range of BMT related research e.g. post-BMT immune reconstitution and vaccination, studies of GVHD (in combination with Rotherham ECP unit). We are an Anthony Nolan collection centre and collaborate in their research programme.  Extension of novel molecularly targeted chemotherapy and immunotherapy agents into Haemato- oncology with Professor Helleday, Professor of Translational Oncology.  The Bone Recovery After Treatment Study (BRATS) designed to capture evidence of bone remodelling recovery during the bone marrow reconstitution phase post-treatment for myeloma. This will provide a solid basis for our proposed trial combining novel anabolic and anti-resorptive therapy.  Sheffield’s track record in MPN’s is being developed further by Dr Thomas, Clinical Lecturer in Haematology, who coordinates the Yorkshire MPN network, and works closely with Dr Zeidler and his lab.

DUTIES OF THE POST

The appointee will, together with Consultant colleagues, contribute to the provision of inpatient, day case and outpatient haemato-oncology and haematopoietic stem cell transplantation (as per JACIE standards). This post comes in anticipation of further consultant expansion and as such there are likely to be changes to working patterns with the development of team job planning for the department.

The appointee(s) will take his/her share in providing emergency cover as appropriate and will be required to cover for colleagues during periods of absence. The frequency of the on-call duties will between 1 in 6 and 1 in 9 for haemato-oncology and BMT cover. The appointee will also be expected to contribute to teaching and supervision and play their part in the leadership and administrative roles within the department e.g. chemotherapy lead, audit lead. Such roles will attract additional PA’d time.

The successful candidate will work according to the terms and conditions of the national consultant contract

A provisional job plan is outlined in the table below, the final job plan will be agreed through discussion with the clinical lead and will be for 10 PA and include 1.5 PA supporting professional activity and appropriate administration time for the clinical role. In summary, the job plan is comprised of:  A ward attending rota, which is shared between three consultants over the year, each covering 17 weeks per year.)  Activities which take place on the weeks in which the post holder is not attending on the ward (25 weeks per year)  Weekly activities (e.g. outpatient clinics and weekly meetings) which take 42 weeks per year  Monthly meetings  Weekend on call (this is shared with all of the Haemato-Oncology Consultants, while the ward attending rota is shared between those within the sub-specialist teams (i.e. Myeloma, Myeloid and Lymphoma).

Activities carried out 42 weeks / year Day Time Activity Type Hours PAs Monday 13:00 -17:00 Outpatient Clinic (MPN) DCC 4 1.0 Tuesday 09:00-10:00 BMT Meeting DCC 1 0.3 Tuesday 10:00-14:00 Outpatient Clinic (BMT) DCC 4 1.0 Wednesday 13:30-17:30 Outpatient Clinic (Myeloid) DCC 4 1.0 Thursday 09:00-10:00 Ward Meeting DCC 1 0.3 Thursday 10:00-13:00 Ward Round DCC 3 0.8 Thursday 13:00-14:00 Radiology Meeting DCC 1 0.3 Friday 11:00-12:00 HODS Integration Meeting DCC 1 0.3 Friday 13:00-16:00 Haemato-Oncology MDT DCC 3 0.8 Subtotal 5.5

Activities carried out monthly Day Time Activity Type Hours PAs* Wednesday 09:00-10:00 Directorate Meeting SPA 1 0.1 Friday 08:00-09:00 Consultants Meeting SPA 1 0.1 Subtotal 0.1

Activities carried out 17 weeks / year - Ward Attending Week Day Time Activity Type Hours PAs* Monday 09:00-13:00 Ward Round DCC 4 0.4 Tuesday 14:00-17:00 Patient Reviews DCC 3 0.3 Wednesday 09:00-11:00 Patient Reviews DCC 2 0.2 Wednesday 11:00-12:00 Chemotherapy Planning Meeting DCC 1 0.1 Wednesday 12:00-13:00 Patient Admin / Review of ICE Results DCC 1 0.1 Thursday 14:00-16:00 Relatives Meetings DCC 2 0.2 Thursday 16:00-17:00 Educational Supervision SPA 1 0.1 Thursday 17-00:18:00 Ward Related Governance DCC 1 0.1 Friday 09:00-11:00 Patient Reviews DCC 2 0.2 Friday 11:00-12:00 Coding DCC 1 0.1 Friday 16:00-17:00 Handover DCC 1 0.1 Subtotal 1.9

Activities carried out 25 weeks / year - Non Ward Attending Week Day Time Activity Type Hours PAs* Monday 09:00-11:00 Dayward Reviews DCC 2 0.3 Monday 11:00-13:00 Clinical Admin DCC 2 0.3 Wednesday 09:00-10:15 Educational Supervision SPA 1.25 0.2 Wednesday 10:15-13:00 SPA (Generic) SPA 2.75 0.4 Thursday 14:00-17:30 SPA (Generic) SPA 3.5 0.5 Friday 09:00-10:00 Clinical Admin DCC 1 0.1 Friday 10:00-11:00 Educational Supervision SPA 1 0.1 Friday 16:00-17:00 SPA (Generic) SPA 1 0.1 Subtotal 2.2

Weekend on call (1 in 9) Day Time Activity Type Hours PAs* Saturday 09:00-12:00 Ward Round DCC 4 0.1 Sunday 09:00-12:00 Ward Round DCC 4 0.1 Subtotal 0.3

TOTAL - DCC 8.3 TOTAL - SPA 1.6 *pro rata as if all activities are 42 weeks / year TOTAL 10.0

An annual review of duties will take place with the Clinical Lead as part of the Job Plan process.

The person appointed will take his/her equal share in providing emergency cover and will be required to cover for colleagues during periods of absence. He/she will have continuing responsibility for patients in his/her care and the proper functioning of the Department.

The appointee will be expected to take an active part in Undergraduate and Postgraduate teaching and training and in this respect, as long as you remain a Consultant within the Trust, you will be regarded as an Honorary Senior Clinical Lecturer in the University of Sheffield, subject to the regulations of the University.

There is office accommodation, access to a PC and secretarial support for this post.

MANAGEMENT ARRANGEMENTS

Clinical Directors are appointed by the Chief Executive for a three year period, subject to annual review. Clinical Leads are appointed by the Clinical Director for an initial three year period, subject to annual review.

Managerially, the Sub-Directorate of Clinical Haematology is within the Directorate of Specialised Medicine (Clinical Director – Prof Steve Green) which is in turn part of the wider Care Group of Specialised Cancer, Specialised Medicine and Rehabilitation (Operations Director, Mr Duncan Campbell, Nurse Director, Mr Martin Salt). There are monthly meetings of the Sub-Directorate and Consultants. The clinical lead is rotational and currently Dr JG Wright. There are monthly meetings of the Sub-Directorate and Consultants. The Sub- Directorate is responsible for providing all clinical haematology services, equating to an annual turnover of just under £27m.

Laboratory Haematology is a member of the Pathology Directorate. The Department is also part of the North Trent Haematology Network. The Laboratory Haematology Administrative Head of Department appointed on a 3 yearly basis and is currently held by Dr H. Barker and there are monthly meetings to determine policy and priorities.

STAFFING

NHS Consultants (with clinical interests) Dr J. A. Snowden Haemato-oncology, Director Transplant Programme, Leukaemias and Myeloma Dr J. G. Wright Haemato-oncology, Lymphoma, Haemoglobinopathy Dr N.J. Morley Haemato-oncology, Acute Lymphoblastic Leukaemias, Lymphoproliferative Disease, General Haematology Dr S. Francis Haemato-oncology, Myeloid disorders, stem cell transplantation Dr H. Kaur Haemato-oncology, Myeloid disorders, stem cell transplantation Dr H. Barker Haemoto-oncology diagnostics, CLL, General Haematology Dr R.M. McLean Haemostasis and Thrombosis, Anti-coagulant service Dr J. Van Veen Haemostasis and Thrombosis, Anti-coagulant service Dr G. Saccullo Haemostasis and Thrombosis, Anti-coagulant service

University Appointments/Honorary Consultants (with clinical interests) Dr M. Makris Haemostasis and Thrombosis (Reader) Dr K. K. Hampton Haemostasis and Thrombosis, Transfusion (Senior Lecturer) Dr A.D. Chantry Haemato-oncology, Myeloma (Senior Lecturer)

NHS Blood and Transplant Posts Dr K. El-Ghariani Consultant in Haematology and Transfusion Medicine, NHSBT

Associate Specialists/ Specialty Doctors Dr S. T. Laidlaw Liaison Haematology at NGH Dr Y Ezaydi Royal Hallamshire Site, Day Case Unit, BMT and Haemato-oncology Dr N Vinogradova Royal Hallamshire Site, Day Case Unit, BMT and Haemato-oncology

Trainees 9 Specialist Registrars 5 Core Trainees

Nursing Staff Charlotte Naylor Matron (Haematology) Catherine Rao Matron Haemostasis and Thrombosis, Anti-coagulant service)

Current trainee staffing will be shared with the new consultant.

THE MAIN CONDITIONS OF SERVICE

The appointment will be in accordance with the Terms and Conditions of Service for Consultants - England (2003) as amended from time to time. The arrangement of duties will be such as may be agreed from time to time between the employing Trust and the person appointed. Whether the successful candidate chooses to accept a whole-time or part-time contract, it is agreed that any private practice undertaken, whether limited or not by the Terms and Conditions of Service, will in no way diminish the level of service that may be expected from him/her in carrying out the duties specified above (Schedule 9 Terms and Conditions of Service).

This Trust supports the concept of Continuing Medical Education and in line with Clinical Governance Senior Clinicians are expected to participate in continuing professional development (CPD) in line with the requirements of revalidation. The Trust, through the Medical Director’s office, has systems in place to support clinicians through appraisal and revalidation.

All staff are required to abide by all Trust Policies and Procedures, details of which can be access via the Trust Intranet, and are required to comply with Mandatory Training requirements. In particular, medical staff should be aware of, and comply with, infection control and safeguarding requirements. HEALTH CLEARANCE & MEDICAL EXAMINATION

This appointment is subject to medical fitness and the appointee may be required to undergo a medical examination and chest X-ray.

Potential applicants should be aware of the Department of Health and GMC/GDC requirements with regard to HIV/AIDS, Tuberculosis, Hepatitis B and Hepatitis C viruses.

The successful candidate must be immune to Hepatitis ‘B’ and Tuberculosis. They will be required to provide, in advance of appointment, evidence of immunity or have a local blood test (as deemed appropriate by the Occupational Health Department).

DBS CLEARANCE

This appointment is subject to an enhanced Disclosure & Barring Service (DBS) clearance. Please note that all charges associated with this check will be passed on to the applicant.

RESIDENCES AND REMOVAL EXPENSES

The successful candidate will be required to maintain his/her place of residence in contact with public telephone services and within a distance of 30 minutes or not more than 10 miles by road from the principal place of work, unless prior specific approval to a greater distance is given by the Trust.

Removal expenses on appointment will be paid in accordance with the Sheffield Teaching Hospitals NHS Foundation Trust Terms and Conditions of Service. These documents can be seen at the offices of the Medical Personnel Department. It should be noted that it is not Trust policy to reimburse interest payment on bridging loans.

VISITS

If candidates wish to visit the hospital(s) concerned, they are at liberty to make arrangements direct with:

Professor Steve Green Dr Josh Wright Clinical Director Clinical Lead – Clinical Haematology Communicable Diseases & Specialised Medicine Royal Hallamshire Hospital Royal Hallamshire Hospital Glossop Road Glossop Road Sheffield S10 2JF Sheffield S10 2JF Telephone: 0114 271 3562 (PA) Telephone: 0114 271 1731

Mr Duncan Campbell Mr Martin Salt Operations Director Nurse Director Specialised Cancer, Medicine and Rehab Specialised Cancer, Medicine and Rehab 3rd Floor Broomcross Building 3rd Floor Broomcross Building Weston Park Hospital Weston Park Hospital Whitham Road Whitham Road Sheffield S10 2SJ Sheffield S10 2SJ Telephone: 0114 226 5011 (PA) Telephone: 0114 271 2943 (PA)

Person Specification

Post: Consultant Haematologist with an interest in Myeloid Disorders and Stem Cell Transplantation Directorate: Communicable Diseases and Specialised Medicine Drawn up by: Dr JG Wright Date: June 2020

Theme Essential How assessed Desirable How assessed Qualifications Full and Specialist registration (with a licence to practise) Application form MD or PhD or equivalent Application with the General Medical Council (GMC), or be eligible form for registration within six months of interview. Name on the specialist register for Haematology or Application form eligible within 6 months of the date of the interview If an applicant is UK trained, they must also be a holder of a Certificate of Completion of Training (CCT), or be within six months of award of CCT by date of interview. Clinical Specialist training in the clinical management of Application form/ experience malignant haematological disorders Interview Specialist training and experience in haematopoietic cell transplantation, including unrelated donor procedures.

Ability to manage haemato-oncological patients at all levels of care (level 1-4).

Ability to supervise and take responsibility for work up, inpatient care and follow up of all levels of haematopoietic cell transplant patients, including unrelated donor procedures. Research Ability to critically assess published research and Application form Publications in Peer reviewed journals. Application incorporate it into clinical practice where appropriate form Theme Essential How assessed Desirable How assessed Ideas for future research whilst in post Interview Teaching and Experience of teaching student doctors and doctors in Application form/ To have the ability to teach to all groups of staff Interview training training at all levels Interview Continuous Evidence of participation in CME/CPD in the last 12 Application form/ Maintenance of a CPD diary or portfolio Application Professional months Interview form / interview Development Management Evidence of the understanding of the systems and Interview/ Awareness of current issues in NHS Interview and structures of NHS Management Application form Experience of working with management groups Administration Clinical Committed to and understands the principles of clinical Interview Active involvement in a clinical governance Interview governance and governance programme audit Experience in performing clinical audit Application form/ Completion and publication of a substantive audit Application Interview project or service improvement project form / interview

Understands the principles outlined in the GMC Interview document Good Medical Practice Understands the requirements of Medical Appraisal and Interview Revalidation Personal Demonstrates behaviour consistent with PROUD values Application attributes (see appendix) form/interview Ensures value for money is considered in all that they do Interview Good time management skills Interview Good oral and written communication skills Application form/ Interview